Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Constantin Lapa

Showing results (231-240 of 269) with videos related to

Pageof 27
Sort By:
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 17, 2025
Comprehensive Characterization via Molecular Imaging, Longitudinal Multisite Sampling, and Autoptic Work-up in Advanced Small Cell Lung Cancer Undergoing SSTR-Directed Radiopharmaceutical TherapyJohanna S Enke, Nic G Reitsam, Sebastian Dintner, et al.
Acta Neuropathologica|January 27, 2026
FAP expression as a marker of malignant transformation enabling in vivo characterization in peripheral nerve sheath tumors: a multimodal and translational studyNic G Reitsam, Alexander Gäble, Lisa Siebenhüter, et al.
Cancers|July 29, 2023
In-Vivo Somatostatin-Receptor Expression in Small Cell Lung Cancer as a Prognostic Image Biomarker and Therapeutic TargetFeyza Şen, Gabriel T Sheikh, Johannes von Hinten, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 19, 2023
Long-Term Nephrotoxicity of <sup>177</sup>Lu-PSMA Radioligand TherapyLisa Steinhelfer, Lukas Lunger, Lisena Cala, et al.
European Journal of Nuclear Medicine and Molecular Imaging|November 3, 2024
Experience of rescue therapy with [<sup>177</sup>Lu]Lu-rhPSMA-10.1 in patients with primary or acquired resistance to [<sup>177</sup>Lu]Lu-PSMA-I&TAlexander Gäble, Alexander Dierks, Andreas Rinscheid, et al.
Cancers|August 28, 2020
The Link between Cytogenetics/Genomics and Imaging Patterns of Relapse and Progression in Patients with Relapsed/Refractory Multiple Myeloma: A Pilot Study Utilizing 18F-FDG PET/CTXiang Zhou, Alexander Dierks, Olivia Kertels, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 5, 2024
C-X-C Motif Chemokine Receptor 4-Directed Scintigraphy Using [<sup>99m</sup>Tc]Tc-Pentixatec in Primary Aldosteronism: A Proof-of-Concept StudyJohanna S Enke, Kathrin Ritzel, Evelyn Asbach, et al.
Scientific Reports|December 1, 2022
Prediction of left lobe hypertrophy after right lobe radioembolization of the liver using a clinical data model with external validationJens M Theysohn, Aydin Demircioglu, Malte Kleditzsch, et al.
Annals of Nuclear Medicine|August 24, 2017
Patterns of uptake of prostate-specific membrane antigen (PSMA)-targeted <sup>18</sup>F-DCFPyL in peripheral gangliaRudolf A Werner, Sara Sheikhbahaei, Krystyna M Jones, et al.
Nuklearmedizin. Nuclear Medicine|January 8, 2024
CXCR4-targeted Theranostics in Hematooncology: Opportunities and ChallengesRudolf Werner, Alexander Haug, Christian Buske, et al.
Pageof 27

Showing results (231-240 of 269) with videos related to

Sort By:
Pageof 27
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 17, 2025
Comprehensive Characterization via Molecular Imaging, Longitudinal Multisite Sampling, and Autoptic Work-up in Advanced Small Cell Lung Cancer Undergoing SSTR-Directed Radiopharmaceutical TherapyJohanna S Enke, Nic G Reitsam, Sebastian Dintner, et al.
Acta Neuropathologica|January 27, 2026
FAP expression as a marker of malignant transformation enabling in vivo characterization in peripheral nerve sheath tumors: a multimodal and translational studyNic G Reitsam, Alexander Gäble, Lisa Siebenhüter, et al.
Cancers|July 29, 2023
In-Vivo Somatostatin-Receptor Expression in Small Cell Lung Cancer as a Prognostic Image Biomarker and Therapeutic TargetFeyza Şen, Gabriel T Sheikh, Johannes von Hinten, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 19, 2023
Long-Term Nephrotoxicity of <sup>177</sup>Lu-PSMA Radioligand TherapyLisa Steinhelfer, Lukas Lunger, Lisena Cala, et al.
European Journal of Nuclear Medicine and Molecular Imaging|November 3, 2024
Experience of rescue therapy with [<sup>177</sup>Lu]Lu-rhPSMA-10.1 in patients with primary or acquired resistance to [<sup>177</sup>Lu]Lu-PSMA-I&TAlexander Gäble, Alexander Dierks, Andreas Rinscheid, et al.
Cancers|August 28, 2020
The Link between Cytogenetics/Genomics and Imaging Patterns of Relapse and Progression in Patients with Relapsed/Refractory Multiple Myeloma: A Pilot Study Utilizing 18F-FDG PET/CTXiang Zhou, Alexander Dierks, Olivia Kertels, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 5, 2024
C-X-C Motif Chemokine Receptor 4-Directed Scintigraphy Using [<sup>99m</sup>Tc]Tc-Pentixatec in Primary Aldosteronism: A Proof-of-Concept StudyJohanna S Enke, Kathrin Ritzel, Evelyn Asbach, et al.
Scientific Reports|December 1, 2022
Prediction of left lobe hypertrophy after right lobe radioembolization of the liver using a clinical data model with external validationJens M Theysohn, Aydin Demircioglu, Malte Kleditzsch, et al.
Annals of Nuclear Medicine|August 24, 2017
Patterns of uptake of prostate-specific membrane antigen (PSMA)-targeted <sup>18</sup>F-DCFPyL in peripheral gangliaRudolf A Werner, Sara Sheikhbahaei, Krystyna M Jones, et al.
Nuklearmedizin. Nuclear Medicine|January 8, 2024
CXCR4-targeted Theranostics in Hematooncology: Opportunities and ChallengesRudolf Werner, Alexander Haug, Christian Buske, et al.
Pageof 27